For following the competition: what moved in each program, several studies read as one move.
- anitocabtagene autoleucel
- domvanalimab
- seladelpar
- + 29 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Gilead Sciences to watchlistEvery Monday by email · turn it off any timePro · free during the beta